SIGN UP
LOG IN
R
ROIV
Roivant Sciences
11.62
0.04+0.30%Opening14:01 05/02 EDT
OPEN/PREV CLOSE11.67/11.58
TODAY RANGE11.56-11.74
VOL5.12M
MARKET CAP8.29B
52 WEEK RANGE8.73-13.06
AVG VOL (3M)6.47M
% TURNOVER0.72%
TURNOVER--
P/E (TTM)-84.5958
% RANGE1.51%
EPS(TTM)-0.1373
P/E(FORWARD)-43.0185
P/B1.611
BVPS7.21
DIVIDEND--
P/S75.08
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.15B
SHARES OUTSTANDING713.55M
NEXT EARNINGS05/28-06/02
FREE FLOAT443.77M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·04/23 16:13
Roivant Sciences: Primed For Growth With A De-Risked Pipeline
Dow Jones·04/21 17:49
Roivant Sciences Price Target Maintained With a $18.00/Share by HC Wainwright & Co.
NASDAQ·04/21 12:42
Analysts Expect XMHQ Will Reach $111
Seeking Alpha·04/21 11:46
Immunovant makes leadership changes
Dow Jones·04/21 11:44
Immunovant CEO Salzmann Retires; Roivant Exec Venker Takes the Helm
TipRanks·04/21 11:12
Immunovant appoints Eric Venker as CEO, Girao as CFO
Reuters·04/21 11:00
IMMUNOVANT INC - TIAGO GIRAO APPOINTED AS CFO OF IMMUNOVANT
NASDAQ·04/14 10:20
Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now?
NASDAQ·04/11 14:04
Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock?
Seeking Alpha·03/31 20:03
Impax Small Cap Fund Q4 2024 Commentary
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.